HARRY GALE: Open Payments
NPI 1194825828 · COTTONWOOD, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 10 payments from 8 companies in 2025. Trend: 2023 $153 · 2024 $426 · 2025 $206
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Viatris Specialty LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
| Globus Medical, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: TRELEGY ELLIPTA, GEMTESA, Veozah, YUPELRI, MINIMED 780G, Senza, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
